HOW CAN WE HELP YOU?

Main contact
+39 02 8224 7044(Outpatient Appointments)
+39 02 8224 7042(Inpatient Admissions)

If you need more information, please contact us by phone.

Centers

Check up & Diagnostics
02 8224 8224
Cardio Center
02 8224 4330

Scientific research

October 12, 2018

Humanitas signs document in defense of the freedom and independence of the...

Humanitas has also signed, at the hands of the scientific director of the Istituto Clinico...
August 3, 2018

Clinic, research and teaching: Prof. Marcacci in an interview

In recent months, the new Centre for the Functional and Biological Reconstruction of the Knee,...
August 3, 2018

Active surveillance in bladder cancer: new study confirms validity

"Active Surveillance for Low Risk Non-muscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study...
July 16, 2018

Immunity and tumors: researcher Martina Molgora receives an award

Dr. Martina Molgora, a young researcher of Humanitas at the laboratory of experimental immunopathology of...
July 5, 2018

Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also...

In Italy only 10% of the diagnoses of liver cancer occur at an early stage...
July 4, 2018

Sepsis: A protein predicts the prognosis and risk of mortality. The results...

An Italian multicentre study, in which Humanitas also participated, confirms the role of Pentraxin3, a...
June 21, 2018

Hepatocarcinoma: the results of the Humanitas study published in The Lancet Oncology

"Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a...
June 19, 2018

New diagnostic techniques in Gastroenterology: Professor Repici’s intervention at Wired Health

Among the speakers at Wired Health, the event organized last March 15 in Milan by...
June 19, 2018

The Image of Artificial Intelligence: Professor Chiti’s Speech at Wired Health

Among the speakers at Wired Health, the event organized last March 15 in Milan by...
June 19, 2018

Cancer and Research: “Moving Target”, the new book by Prof. Mantovani

Thousands of new cases every day in Italy alone and 500 deaths: these are the...
June 19, 2018

Ulcerative colitis, the first results of a new study with apremilast presented...

Ulcerative colitis is a chronic inflammatory disease that affects the rectum and may affect part...
June 12, 2018

Blood tumors and genome studies: in Humanitas a diagnostic test from a...

Blood cancers, such as leukemia and lymphomas, are among the top ten causes of death...
June 12, 2018

Severe Infarction: A New Therapeutic Opportunity from New Generation Anticoagulant Drugs

For patients with a severe heart attack, adding a new generation anticoagulant drug (DOAC), now...
June 12, 2018

The role of Research and future prospects: Prof. Mantovani on Rai Radio...

Professor Alberto Mantovani, Scientific Director of Humanitas, spoke in the Radio programme also broadcasted on...
June 12, 2018

A new European study coordinated by Humanitas for the treatment of ALS...

The "TUDCA-ALS Kick-off meeting" will be held on Thursday 8 and Friday 9 February at...
May 23, 2018

Psoriasis and psoriatic arthritis: a study on twins in Humanitas

Twins share DNA and are often studied because of their peculiarity. In Italy, the National...
May 23, 2018

Tumors: Prof. Mantovani and Dr. Garlanda explain the discovery of IL-1R8, the...

An Italian study, directed and coordinated by Humanitas, funded by AIRC and published in Nature,...
April 13, 2018

Myelodysplastic syndromes: new drugs and personalized medicine

Myelodysplastic syndromes or myelodysplasia are blood diseases that affect older people in particular. We talk...
Right Arrow